Publications

Filters: policy
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Medicines For Europe Country Specific Market Access Policies

24 May 2018

Policy

Read More

Position paper on Best Procurement Practices

28 April 2018

Policy

Read More

IGBA position on identification of biological, including biosimilar medicines (2018 update of facts & figures)

20 April 2018

Policy

Read More

Life Science Industry Coalition Position paper

14 December 2017

Policy

Read More

Joint statement – European health community calls on the EU and UK to prioritise patients as crunch Article 50 decision approaches

7 December 2017

Policy

Today a group of organisations representing patients, healthcare professionals and […]

Read more

Position Paper: for an ambitious EU industrial strategy

24 October 2017

Policy

Read More

SPC manufacturing waiver

24 October 2017

Policy

SME Intergroup Conclusions – Boosting SMEs through the SPC Waiver […]

Read more

Position Paper Medicines Shortages

29 September 2017

Policy

Position paper Reading list Report Address medicine shortages in Europe

Read more

Fighting counterfeit medicines in Europe: the effect on access to medicines

14 September 2017

Policy

The implementation of the Falsified Medicines Directive, and its Delegated […]

Read more

US FDA Advisory committee hears first-hand about the decade of EU experience with biosimilar medicines use

13 July 2017

Policy

Medicines for Europe Director General Adrian van de Hoven participated […]

Read more

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]